Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Rxi Pharmaceuticals Corp. (MM) (RXII)
Rxi Pharmaceuticals Corp. (MM) (RXII) News

RXII

RXI Pharmaceuticals Corporation (RXII)

Rxi Pharmaceuticals Corp. (MM)

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:RXII

<< Previous 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 Next >>

Date	Time	Source	Headline	Symbol	Company
04/02/2015	11:16AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/30/2015	7:41AM	Edgar (US Regulatory)	Annual Report (10-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/30/2015	7:39AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/30/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals Reports Fourth Quarter and Year End 2014 Financial Results and Recent Corporate Highlights	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/27/2015	9:02AM	PR Newswire (US)	RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) T...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/24/2015	4:33PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/23/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals Reports Positive Advancements in its Dermatology Programs at the Occasion of the 73rd Annual Meeting of t...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/16/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals to Webcast Fourth Quarter and Year End 2014 Financial Results on Monday, March 30, 2015	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
03/11/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals to Present at the 73rd Annual Meeting of the American Academy of Dermatology	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/25/2015	3:58PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/25/2015	3:52PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/25/2015	3:45PM	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/18/2015	9:22AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/11/2015	9:41AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/05/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals Announces Closing of the Exclusive Global Licensing Agreement to Samcyprone™ with Hapten Pharmaceutical...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/03/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals Strengthens Intellectual Property Portfolio for Ocular Indications	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
02/02/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals to Present at the 17th Annual BIO CEO & Investor Conference	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/27/2015	4:31PM	Edgar (US Regulatory)	Amended Statement of Ownership (sc 13g/a)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/23/2015	8:51AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/20/2015	11:57AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
01/05/2015	7:02AM	PR Newswire (US)	RXi Pharmaceuticals to Present at the 7th Annual Biotech Showcase™	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/31/2014	8:41AM	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/22/2014	7:02AM	PR Newswire (US)	RXi Pharmaceuticals Issues Open Letter to Shareholders	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/19/2014	4:20PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/19/2014	4:17PM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/19/2014	7:05AM	PR Newswire (US)	RXi Pharmaceuticals Expands its Clinical Pipeline with an Exclusive Global License for a Second Phase 2 Clinical Compound	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/18/2014	4:36PM	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
12/17/2014	7:02AM	PR Newswire (US)	RXi Pharmaceuticals Announces Sustained Effect of RXI-109 at Three Months Post Scar Revision Surgery and the Completion of En...	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
11/13/2014	7:21AM	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)
11/13/2014	7:10AM	PR Newswire (US)	RXi Pharmaceuticals Reports Financial Results for the Third Quarter of 2014	NASDAQ:RXII	Rxi Pharmaceuticals Corp. (MM)